TABLE 3.

Best overall response ^a in the overall safety population and by triple‐negative disease status

Best overall response, n (%)	Safety population (N = 76)	Not TNBC (n = 58)	TNBC (n = 17)
Complete response	2 (2.6)	0	2 (11.8)
Partial response	12 (15.8)	10 (17.2)	2 (11.8)
Stable disease	21 (27.6)	17 (29.3)	4 (23.5)
Progressive disease b	24 (31.6)	17 (29.3)	6 (35.3)
Not available/missing c	17 (22.4)	14 (24.1)	3 (17.6)

Abbreviation: TNBC, triple‐negative breast cancer.

^a Tumour response was assessed according to physician's usual clinical practice.

^b One patient with a best overall response of progressive disease had unknown TNBC status.

^c Scans were performed at the investigator's discretion and only after a patient had received at least three cycles of eribulin.